Filing Flows › Comparisons › PLX vs FENC
Protalix BioTherapeutics vs Fennec Pharmaceuticals: PLX and FENC compared
Protalix BioTherapeutics is the larger company: $19.9M of revenue in its latest quarter (Q2 2026) against $17.9M for Fennec Pharmaceuticals (Q2 2026). Fennec Pharmaceuticals is growing faster (+85% against +27% a year earlier). Protalix BioTherapeutics is more profitable, with an operating margin of 23.5% against 9.7%.
Where the money goes: PLX and FENC
Protalix BioTherapeutics (PLX) · Q2 2026
Protalix BioTherapeutics, Q2 2026: revenue $19.9M (+27% year over year), operating margin 23.5%, net earnings $3.8M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.
Fennec Pharmaceuticals (FENC) · Q2 2026
Fennec Pharmaceuticals, Q2 2026: revenue $17.9M (+85% year over year), operating margin 9.7%, net earnings $2.0M, operating cash flow $50K. The chart follows the revenue to costs, profit and cash.
| Protalix BioTherapeutics (PLX) | Fennec Pharmaceuticals (FENC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $19.9M | $17.9M |
| Revenue growth, Y/Y | +27% | +85% |
| Operating margin | 23.5% | 9.7% |
| Net earnings | $3.8M | $2.0M |
| Net margin | 19.0% | 11.0% |
| Operating cash flow | −$10.4M | $50K |
Where the revenue comes from
Protalix BioTherapeutics
- GOODS: $19.8M (100%)
- LICENSE AND R&D SERVICES: $68K (0%)
Fennec Pharmaceuticals
- PEDMARK product sales, net: $17.2M (96%)
- Other revenue: $710K (4%)
Questions
Which is bigger, Protalix BioTherapeutics or Fennec Pharmaceuticals?
Protalix BioTherapeutics is the larger company: $19.9M of revenue in its latest quarter (Q2 2026) against $17.9M for Fennec Pharmaceuticals (Q2 2026).
Is Protalix BioTherapeutics or Fennec Pharmaceuticals growing faster?
Fennec Pharmaceuticals is growing faster (+85% against +27% a year earlier).
Which is more profitable, Protalix BioTherapeutics or Fennec Pharmaceuticals?
Protalix BioTherapeutics is more profitable, with an operating margin of 23.5% against 9.7%.
More: Protalix BioTherapeutics earnings · how Protalix BioTherapeutics makes money · Fennec Pharmaceuticals earnings · how Fennec Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.